Could $1 Stock Be Sitting on a Billion-Dollar Discovery?

This $1 stock has already made its mark with a listing on the prestigious NYSE. Now, it's sitting on prime land in one of America's richest gold districts, with the potential for a billion-dollar discovery. For savvy investors, this may be a $1 "Golden Ticket" to massive returns.

Popular

Sanofi Expands Insulin Savings Program To Cover All US Patients

The U.S. Food and Drug Administration removed the Risk Evaluation and Mitigation Strategies (REMS) program for Caprelsa (vandetanib), a thyroid cancer medication manufactured by Sanofi SA’s (NASDAQ: SNY) Genzyme Corporation.

A drug made from marijuana reduced back pain in a large study

WASHINGTON (AP) — An experimental medication made from successfully reduced back pain in a new study, offering further support for the drug’s potential in treating one of the most common forms of .

The #1 Energy Play for 2025 - Ad

Expert Reveals: The #1 Energy Play for 2025. "We're Entering the Greatest Energy Bull Market Since the Industrial Revolution" - Larry Benedict

Extra Money in Your Bank Account? Here's Where You Should Consider Investing - Ad

Got some extra cash sitting in your account? Now might be the perfect time to put it to work. The Motley Fool's latest "Double Down" stock recs reveal where their analysts believe the smartest money is headed next.

Government shutdown could be the longest ever, Speaker Johnson warns

WASHINGTON (AP) — Republican predicted Monday the federal may become the longest in history, saying he “won't negotiate” with Democrats until they hit pause on their and reopen.

CDC Reverses Hundreds Of Layoff Notices After Firing 1,300 Employees Amid Government Shutdown

The CDC laid off around 1,300 employees but reversed hundreds of notices within hours amid broader staffing disruptions during the shutdown.

REVEALED: Something Big Happening West of Pittsburgh - Ad

What I just learned about the situation unfolding in Appalachia is stunning... And you need to see it for yourself. Once you see what's really going on in small town America, you'll understand why I rushed this interview to you today.

Could $1 Stock Be Sitting on a Billion-Dollar Discovery? - Ad

This $1 stock has already made its mark with a listing on the prestigious NYSE. Now, it's sitting on prime land in one of America's richest gold districts, with the potential for a billion-dollar discovery. For savvy investors, this may be a $1 "Golden Ticket" to massive returns.

Zenas Biopharma Raises $120 Million To Secure Global Rights To Multiple Sclerosis Drug

Zenas BioPharma secures global rights to orelabrutinib in multiple sclerosis, expands autoimmune pipeline, and raises $120 million in private placement.

Trump's $100,000 H-1B visa fee threatens rural schools and hospitals reliant on immigrant workers

SIOUX FALLS, S.D. (AP) — When Rob Coverdale started his job in 2023 as superintendent of the K-12 Crow Creek Tribal School in South Dakota, there were 15 unfilled teaching positions.

RFK Jr Issues 2025 Warning [Seniors Most at Risk?] - Ad

For years liberals have called RFK Jr a QUACK... an alarmist... and a conspiracy theorist. But now it appears he was right about a COVID lab leak... He was right about microplastics... And he was right about FDA corruption. Now, he's issued a terrifying new warning that Americans need to hear in 2025. Millions are in the crosshairs... And if you were born before Jan 1st, 1965, this affects you most of all.

Lawsuit seeks to stop Trump's $100,000 fee for H-1B visas

SEATTLE (AP) — In what appears to be the first major challenge to the new applications, a coalition of health care providers, religious groups, university professors and others filed a federal lawsuit Friday to stop the plan, saying it has “thrown employers, workers and federal agencies into chaos.”

2 Under-The-Radar Health-Tech Stocks With Surging Momentum Scores

Two under-the-radar health-tech stocks are seeing their Momentum scores surge in Benzinga's Edge Stock Rankings.

Could $1 Stock Be Sitting on a Billion-Dollar Discovery? - Ad

This $1 stock has already made its mark with a listing on the prestigious NYSE. Now, it's sitting on prime land in one of America's richest gold districts, with the potential for a billion-dollar discovery. For savvy investors, this may be a $1 "Golden Ticket" to massive returns.

PepsiCo's new challenge: Making its chips and sodas colorful without artificial dyes

VALHALLA, New York (AP) — Pepsi has a new challenge: keeping products like and vivid and colorful without the that U.S. consumers are increasingly rejecting.

Walmart sets a timeline for removing synthetic dyes and other additives from its food brands

NEW YORK (AP) — said Wednesday that it plans to remove and 30 other ingredients, including some preservatives, artificial sweeteners and fat substitutes, from its store brands sold in the United States by January 2027.

The #1 Retirement Play for 2025 - Ad

Expert Reveals: The #1 Retirement Play for 2025. "We're Entering the Greatest Energy Bull Market Since the Industrial Revolution" - Larry Benedict

Pfizer agrees to lower prescription drug costs for Medicaid in a deal with Trump

WASHINGTON (AP) — Drugmaker Pfizer has agreed to lower drug costs and invest $70 billion in U.S. manufacturing under a deal struck with the Trump administration, President Donald Trump said Tuesday.

Family's attorney questions Universal's response to roller coaster injuries after man's death

ORLANDO, Fla. (AP) — Multiple people have reached out with related stories to the family of a two weeks ago while riding the new Stardust Racers roller coaster at Universal's Epic Universe theme park, the attorney for the man's family said Tuesday.

This One Oil & Gas Stock Beat Every Member of the Magnificent Seven - Ad

Get the name and ticker of this incredible stock here. Plus get details of a deceptively simple strategy with incredible upside and less risk than buying and holding stocks. Larry Benedict just went public with what he's calling "the best retirement play for 2025."

Travelers bothered by their flight's pollution can pay to reduce it elsewhere. Do offsets work?

So you're booking your flight, and just when you're about to check out, the airline asks if you'd like to pay a little something to offset your share of the flight's pollution. Or, maybe you're an environmentally minded person, and you've heard you can buy these things called carbon offsets.

Regulators struggle to keep up with the fast-moving and complicated landscape of AI therapy apps

In the absence of stronger federal regulation, some states have begun regulating apps that offer AI “therapy” as more people turn to .

Are You Ready for the Next Market Revolution? - Ad

A massive market revolution is already underway-and most investors don't even see it coming. This breakthrough technology could unleash trillions in new wealth, with the potential to be worth as much as multiple Teslas. The question is: will you be positioned to profit when it takes off?

Hims & Hers Powers YieldMax's Latest Options-Based Income ETF

YieldMax ETFs grew its expanding lineup of income-oriented funds on Tuesday with the introduction of the YieldMax HIMS Option Income Strategy ETF (NYSE: HIYY).

RFK Jr's FINAL Warning For American Seniors - Ad

For years liberals have called RFK Jr a QUACK... an alarmist... and a conspiracy theorist. But now it appears he was right about a COVID lab leak... He was right about microplastics... And he was right about FDA corruption. Now, he's issued a terrifying new warning that Americans need to hear in 2025. Millions are in the crosshairs... And if you were born before Jan 1st, 1965, this affects you most of all.

Woman sues Universal Orlando over injuries from same roller coaster in which man died after ride

ORLANDO, Fla. (AP) — A woman has sued Universal Orlando Resort, claiming she was injured on a roller coaster at its newest theme park. The lawsuit, filed Wednesday, comes a week from blunt impact injuries after going on the same ride.

Intellia Highlights Clinical Improvements With One-Time Dose Of Experimental Drug

Intellia Therapeutics Inc. (NASDAQ: NTLA) on Thursday released longer-term follow-up data from the ongoing Phase 1 study of investigational nexiguran ziclumeran (nex-z) for the treatment of hereditary ATTR amyloidosis with

Claim Your Share of $5.39 Billion in AI Equity Checks - Ad

Virtually every AI model is built off stolen data...so it's only fair that you deserve some kind of compensation...And the U.S. government seems to agree. Which is why you could now receive as much as $3,452.50 per month on average from "AI Equity Checks."

Bill Clinton sees this year's Clinton Global Initiative as a 'counterweight' to aid cuts

NEW YORK (AP) — Former President Bill Clinton opened the annual meeting of the Clinton Global Initiative Wednesday with a list of things that worry him.

Novartis, AbbVie Face Legal Defeat Over 340B Contract Pharmacies

A judge upholds Maine's contract pharmacy law, rejecting drugmakers' claims that it conflicts with federal rules governing the 340B drug discount program.

The #1 Energy Play for 2025 - Ad

Expert Reveals: The #1 Energy Play for 2025. "We're Entering the Greatest Energy Bull Market Since the Industrial Revolution" - Larry Benedict

State of Connecticut settles lawsuit over convict's killing of visiting nurse for $2 million

HARTFORD, Conn. (AP) — Connecticut officials have agreed to a $2.25 million settlement of a lawsuit over a sex offender's killing of visiting nurse Joyce Grayson at a halfway house in 2023 — a case that for home health care workers across the country.

Bristol Myers Squibb Franchise Gains Momentum With Phase 3 Results In Multiple Myeloma Patients

Bristol Myers Squibb reported positive Phase 3 results for iberdomide in multiple myeloma; analysts eye CELMoDs as key to future growth.

Recommended

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright activatrade.ca
Privacy Policy | Terms of Service